Shenzhen Yingkeda Technology Co.,Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen Yingkeda Technology Co.,Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OYEFIT. The owner is based in Shenzhen, Guangdong.
3rd&4th floors, 88 Xingwang Road, Sigang
Henggang Street, Longgang District
Shenzhen, Guangdong 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Yingkeda Technology Co.,Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Yingkeda Technology Co.,Ltd. have?
Shenzhen Yingkeda Technology Co.,Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Shenzhen Yingkeda Technology Co.,Ltd. file in?
Shenzhen Yingkeda Technology Co.,Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen Yingkeda Technology Co.,Ltd.'s most well-known trademarks?
Shenzhen Yingkeda Technology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as OYEFIT. These are among 2 currently registered trademarks in the portfolio.
What is Shenzhen Yingkeda Technology Co.,Ltd.'s trademark registration success rate?
Shenzhen Yingkeda Technology Co.,Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.